A Clinical Study of SCTC21C in Participants With CD38+ Hematologic Malignancies

Clinical trial NCT06252298 · RECRUITING

Trial details

NCT number: NCT06252298
Sponsor: Sinocelltech Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory Hematologic Malignancies

Start date: 2024-02-28
Primary completion: 2025-08-28
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.